#COVID19 #risksociety
Smallpox, Health care, Vaccination, Vaccine, World Health Organization, Public health

The World Is Winning—and Losing—the Vaccine Race

Le Sep 20, 2020
@IlonaKickbusch a partagé
RT @adam_tooze: A while back I did an essay about U. Beck’s concept of “risk society”. In this new piece for @ForeignPolicy I analyze the vaccine race as a 1st taste of political economy of the future. We may want a black box, but in risk society politics is everywhere. https://t.co/XIb1KVR96m https://t.co/WiaPhJQeZv
Open

Immunization to COVID-19 is supposed to solve our problems—but it's starting to trigger even bigger ones.

foreignpolicy.com
Le Sep 20, 2020
@IlonaKickbusch a partagé
RT @adam_tooze: A while back I did an essay about U. Beck’s concept of “risk society”. In this new piece for @ForeignPolicy I analyze the vaccine race as a 1st taste of political economy of the future. We may want a black box, but in risk society politics is everywhere. https://t.co/XIb1KVR96m https://t.co/WiaPhJQeZv
Open

The World Is Winning—and Losing—the Vaccine Race

The World Is Winning—and Losing—the Vaccine Race

Immunization to COVID-19 is supposed to solve our problems—but it's starting to trigger even bigger ones.

Health first: Finding resilience in pharmaceuticals

Health first: Finding resilience in pharmaceuticals

Searching for resilient income as COVID-19 prompts new appreciation of healthcare.

FT Health: We’re not all in this together

FT Health: We’re not all in this together

Inequalities laid bare by pandemic, Seth Berkley on vaccines, malaria setback

The Little-Known Coalition Tasked With Saving The World From COVID-19

The Little-Known Coalition Tasked With Saving The World From COVID-19

Vaccine manufacturing veteran James Robinson details a little-known organization (i.e., the Coalition for Epidemic Preparedness Innovation [CEPI])...

Coronavirus: Will someone develop a vaccine?

Coronavirus: Will someone develop a vaccine?

Global pharmaceutical companies may not see enough profitability from developing a Covid-19 vaccine.

The Limits of Altruism A Global Scramble for the Coming Coronavirus Vaccine

The Limits of Altruism A Global Scramble for the Coming Coronavirus Vaccine

A vast rivalry is developing between the U.S. and China in the race to develop a coronavirus vaccine. The health of billions of people depends on the outcome. How can the vaccine be fairly ...

The Tragedy of Vaccine Nationalism

The Tragedy of Vaccine Nationalism

Global cooperation on vaccine allocation would be the most efficient way to disrupt the spread of the virus

Advancing Research and Planning for the Equitable Distribution of a Covid-19 Vaccine

Advancing Research and Planning for the Equitable Distribution of a Covid-19 Vaccine

With more than 12 million confirmed cases of Covid-19 worldwide, and with more than 550,000 deaths attributed to complications from infection with the novel coronavirus, identifying and ...

A pandemic killing tens of millions of people is a real possibility — and we are not prepared for it

A pandemic killing tens of millions of people is a real possibility — and we are not prepared for it

A century ago, the Spanish flu killed more than 50 million people. The world is at risk of another pandemic of similar scale.

The World Needs the WHO — and the Case for Reform

The World Needs the WHO — and the Case for Reform

The WHO plays an essential role in supporting global health efforts worldwide, but it has come under fire for its handling of the COVID-19 crisis.

Profits and Pride at Stake, the Race for a Vaccine Intensifies

Profits and Pride at Stake, the Race for a Vaccine Intensifies

Governments, companies and academic labs are accelerating their efforts amid geopolitical crosscurrents, questions about safety and the challenges of producing enough doses for billions of ...

WHO, Pharma, Gates and Government: Who’s Calling the Shots?

WHO, Pharma, Gates and Government: Who’s Calling the Shots?

Survey reveals that age and parenthood had more to do with vaccine hesitancy, with young adults and parents being less supportive of mandatory vaccination.

COVID-19: how researchers around the world are racing to understand the virus and prevent future outbreaks

COVID-19: how researchers around the world are racing to understand the virus and prevent future outbreaks

The key coronavirus (COVID-19) questions that researchers are working to answer, including where it came from, how the virus spreads, and the latest on potential treatments and vaccines.

US, China absent from international vaccine effort

US, China absent from international vaccine effort

In laboratories around the world, hundreds of scientists are racing to develop a vaccine for the coronavirus and end the pandemic that has brought global commerce, travel and much of ...

Confusion spreads over system to determine priority access to Covid-19 vaccines

Confusion spreads over system to determine priority access to Covid-19 vaccines

Public health experts are expressing concern and confusion over the process by which people will be given priority access to the vaccines.

The Danger of Vaccine Nationalism

The Danger of Vaccine Nationalism

Countries must deploy a coordinated strategy based on science, not politics.

Brigham and Women's president Elizabeth Nabel follows Moncef Slaoui off Moderna's board

Brigham and Women's president Elizabeth Nabel follows Moncef Slaoui off Moderna's board

Amid recent scrutiny on how Moderna’s top executives have been cashing out their increasingly valuable shares, the biotech is parting ways with a board member who’s also heading a hospital ...

The race for a vaccine: how Trump's 'America First' approach slows the global search

The race for a vaccine: how Trump's 'America First' approach slows the global search

Unlike with HIV and Ebola the US government has turned its back on the global coalition fighting the disease in favour of a go-it-alone approach

The Sociologist Who Could Save Us From Coronavirus

The Sociologist Who Could Save Us From Coronavirus

Ulrich Beck was a prophet of uncertainty—and the most important intellectual for the pandemic and its aftermath.

Pfizer aims for 10-20 million doses of coronavirus vaccine by end-2020

Pfizer aims for 10-20 million doses of coronavirus vaccine by end-2020

Pfizer aims to make 10-20 million doses of a coronavirus vaccine it is developing with Germany's BioNtech by the end of 2020 for emergency use should it pass tests, the U.S. drugmaker's ...

Covid-19 Vaccine Developers Prepare Joint Pledge on Safety, Standards

Covid-19 Vaccine Developers Prepare Joint Pledge on Safety, Standards

Drug makers developing Covid-19 vaccines plan to issue a pledge not to seek government approval until the shots have proven to be safe and effective, an unusual joint move among rivals that ...